(Q43687803)

25 November 2017

Tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines (English)

1 reference

25 November 2017

1 reference

1 reference

Liu W

1

1 reference

25 November 2017

Bodle E

2

1 reference

25 November 2017

Chen JY

3

1 reference

25 November 2017

Gao M

4

1 reference

25 November 2017

Rosen GD

5

1 reference

25 November 2017

Broaddus VC

6

1 reference

25 November 2017

1 July 2001

1 reference

American Journal of Respiratory Cell and Molecular Biology

25 November 2017

1 reference

25 November 2017

25

1 reference

25 November 2017

111-118

1 reference

25 November 2017

1

1 reference

Apoptosis and drug response

25 November 2017

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Preparation and characterization of an endogenously fluorescent annexin for detection of apoptotic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Apoptosis: checkpoint at the mitochondrial frontier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Mitochondrial control of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Two CD95 (APO-1/Fas) signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Caspase-8 activation and bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Caspases disrupt mitochondrial membrane barrier function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

Mitochondria and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.1.4472

21 January 2018

Identifiers

DOI

10.1165/AJRCMB.25.1.4472

1 reference

25 November 2017

1 reference